22nd Century Group, a plant biotechnology company and leader in tobacco harm reduction, has announced that it will open specialized laboratories in western New York, USA, dedicated to new scientific research at substantially lower costs than sponsored research projects at third-party universities.
Paul J. Rushton, Ph.D., the company’s vice president of plant biotechnology, will lead the new scientific initiative. The laboratories will accelerate the development of new nicotine-free tobacco varieties as well as the invention of important tobacco products.
“This is a very exciting time for our company,” said Rushton. “Our new laboratories will provide 22nd Century with the in-house capabilities to rapidly expand our genomics-based research and to accelerate commercialization of our technologies.”